Cargando…

Synergy Between Beta-Lactams and Lipo-, Glyco-, and Lipoglycopeptides, Is Independent of the Seesaw Effect in Methicillin-Resistant Staphylococcus aureus

Methicillin-resistant S. aureus (MRSA) are resistant to beta-lactams, but synergistic activity between beta-lactams and glycopeptides/lipopeptides is common. Many have attributed this synergy to the beta-lactam-glycopeptide seesaw effect; however, this association has not been rigorously tested. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Rutan, Barreras Beltran, Ismael A., Ashford, Nathaniel K., Penewit, Kelsi, Waalkes, Adam, Holmes, Elizabeth A., Hines, Kelly M., Salipante, Stephen J., Xu, Libin, Werth, Brian J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503943/
https://www.ncbi.nlm.nih.gov/pubmed/34646861
http://dx.doi.org/10.3389/fmolb.2021.688357
_version_ 1784581230463811584
author Zhang, Rutan
Barreras Beltran, Ismael A.
Ashford, Nathaniel K.
Penewit, Kelsi
Waalkes, Adam
Holmes, Elizabeth A.
Hines, Kelly M.
Salipante, Stephen J.
Xu, Libin
Werth, Brian J.
author_facet Zhang, Rutan
Barreras Beltran, Ismael A.
Ashford, Nathaniel K.
Penewit, Kelsi
Waalkes, Adam
Holmes, Elizabeth A.
Hines, Kelly M.
Salipante, Stephen J.
Xu, Libin
Werth, Brian J.
author_sort Zhang, Rutan
collection PubMed
description Methicillin-resistant S. aureus (MRSA) are resistant to beta-lactams, but synergistic activity between beta-lactams and glycopeptides/lipopeptides is common. Many have attributed this synergy to the beta-lactam-glycopeptide seesaw effect; however, this association has not been rigorously tested. The objective of this study was to determine whether the seesaw effect is necessary for synergy and to measure the impact of beta-lactam exposure on lipid metabolism. We selected for three isogenic strains with reduced susceptibility to vancomycin, daptomycin, and dalbavancin by serial passaging the MRSA strain N315. We used whole genome sequencing to identify genetic variants that emerged and tested for synergy between vancomycin, daptomycin, or dalbavancin in combination with 6 beta-lactams with variable affinity for staphylococcal penicillin binding proteins (PBPs), including nafcillin, meropenem, ceftriaxone, ceftaroline, cephalexin, and cefoxitin, using time-kills. We observed that the seesaw effect with each beta-lactam was variable and the emergence of the seesaw effect for a particular beta-lactam was not necessary for synergy between that beta-lactam and vancomycin, daptomycin, or dalbavancin. Synergy was more commonly observed with vancomycin and daptomycin based combinations than dalbavancin in time-kills. Among the beta-lactams, cefoxitin and nafcillin were the most likely to exhibit synergy using the concentrations tested, while cephalexin was the least likely to exhibit synergy. Synergy was more common among the resistant mutants than the parent strain. Interestingly N315-D1 and N315-DAL0.5 both had mutations in vraTSR and walKR despite their differences in the seesaw effect. Lipidomic analysis of all strains exposed to individual beta-lactams at subinhibitory concentrations suggested that in general, the abundance of cardiolipins (CLs) and most free fatty acids (FFAs) positively correlated with the presence of synergistic effects while abundance of phosphatidylglycerols (PGs) and lysylPGs mostly negatively correlated with synergistic effects. In conclusion, the beta-lactam-glycopeptide seesaw effect and beta-lactam-glycopeptide synergy are distinct phenomena. This suggests that the emergence of the seesaw effect may not have clinical importance in terms of predicting synergy. Further work is warranted to characterize strains that don’t exhibit beta-lactam synergy to identify which strains should be targeted with combination therapy and which ones cannot and to further investigate the potential role of CLs in mediating synergy.
format Online
Article
Text
id pubmed-8503943
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-85039432021-10-12 Synergy Between Beta-Lactams and Lipo-, Glyco-, and Lipoglycopeptides, Is Independent of the Seesaw Effect in Methicillin-Resistant Staphylococcus aureus Zhang, Rutan Barreras Beltran, Ismael A. Ashford, Nathaniel K. Penewit, Kelsi Waalkes, Adam Holmes, Elizabeth A. Hines, Kelly M. Salipante, Stephen J. Xu, Libin Werth, Brian J. Front Mol Biosci Molecular Biosciences Methicillin-resistant S. aureus (MRSA) are resistant to beta-lactams, but synergistic activity between beta-lactams and glycopeptides/lipopeptides is common. Many have attributed this synergy to the beta-lactam-glycopeptide seesaw effect; however, this association has not been rigorously tested. The objective of this study was to determine whether the seesaw effect is necessary for synergy and to measure the impact of beta-lactam exposure on lipid metabolism. We selected for three isogenic strains with reduced susceptibility to vancomycin, daptomycin, and dalbavancin by serial passaging the MRSA strain N315. We used whole genome sequencing to identify genetic variants that emerged and tested for synergy between vancomycin, daptomycin, or dalbavancin in combination with 6 beta-lactams with variable affinity for staphylococcal penicillin binding proteins (PBPs), including nafcillin, meropenem, ceftriaxone, ceftaroline, cephalexin, and cefoxitin, using time-kills. We observed that the seesaw effect with each beta-lactam was variable and the emergence of the seesaw effect for a particular beta-lactam was not necessary for synergy between that beta-lactam and vancomycin, daptomycin, or dalbavancin. Synergy was more commonly observed with vancomycin and daptomycin based combinations than dalbavancin in time-kills. Among the beta-lactams, cefoxitin and nafcillin were the most likely to exhibit synergy using the concentrations tested, while cephalexin was the least likely to exhibit synergy. Synergy was more common among the resistant mutants than the parent strain. Interestingly N315-D1 and N315-DAL0.5 both had mutations in vraTSR and walKR despite their differences in the seesaw effect. Lipidomic analysis of all strains exposed to individual beta-lactams at subinhibitory concentrations suggested that in general, the abundance of cardiolipins (CLs) and most free fatty acids (FFAs) positively correlated with the presence of synergistic effects while abundance of phosphatidylglycerols (PGs) and lysylPGs mostly negatively correlated with synergistic effects. In conclusion, the beta-lactam-glycopeptide seesaw effect and beta-lactam-glycopeptide synergy are distinct phenomena. This suggests that the emergence of the seesaw effect may not have clinical importance in terms of predicting synergy. Further work is warranted to characterize strains that don’t exhibit beta-lactam synergy to identify which strains should be targeted with combination therapy and which ones cannot and to further investigate the potential role of CLs in mediating synergy. Frontiers Media S.A. 2021-09-09 /pmc/articles/PMC8503943/ /pubmed/34646861 http://dx.doi.org/10.3389/fmolb.2021.688357 Text en Copyright © 2021 Zhang, Barreras Beltran, Ashford, Penewit, Waalkes, Holmes, Hines, Salipante, Xu and Werth. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Molecular Biosciences
Zhang, Rutan
Barreras Beltran, Ismael A.
Ashford, Nathaniel K.
Penewit, Kelsi
Waalkes, Adam
Holmes, Elizabeth A.
Hines, Kelly M.
Salipante, Stephen J.
Xu, Libin
Werth, Brian J.
Synergy Between Beta-Lactams and Lipo-, Glyco-, and Lipoglycopeptides, Is Independent of the Seesaw Effect in Methicillin-Resistant Staphylococcus aureus
title Synergy Between Beta-Lactams and Lipo-, Glyco-, and Lipoglycopeptides, Is Independent of the Seesaw Effect in Methicillin-Resistant Staphylococcus aureus
title_full Synergy Between Beta-Lactams and Lipo-, Glyco-, and Lipoglycopeptides, Is Independent of the Seesaw Effect in Methicillin-Resistant Staphylococcus aureus
title_fullStr Synergy Between Beta-Lactams and Lipo-, Glyco-, and Lipoglycopeptides, Is Independent of the Seesaw Effect in Methicillin-Resistant Staphylococcus aureus
title_full_unstemmed Synergy Between Beta-Lactams and Lipo-, Glyco-, and Lipoglycopeptides, Is Independent of the Seesaw Effect in Methicillin-Resistant Staphylococcus aureus
title_short Synergy Between Beta-Lactams and Lipo-, Glyco-, and Lipoglycopeptides, Is Independent of the Seesaw Effect in Methicillin-Resistant Staphylococcus aureus
title_sort synergy between beta-lactams and lipo-, glyco-, and lipoglycopeptides, is independent of the seesaw effect in methicillin-resistant staphylococcus aureus
topic Molecular Biosciences
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503943/
https://www.ncbi.nlm.nih.gov/pubmed/34646861
http://dx.doi.org/10.3389/fmolb.2021.688357
work_keys_str_mv AT zhangrutan synergybetweenbetalactamsandlipoglycoandlipoglycopeptidesisindependentoftheseesaweffectinmethicillinresistantstaphylococcusaureus
AT barrerasbeltranismaela synergybetweenbetalactamsandlipoglycoandlipoglycopeptidesisindependentoftheseesaweffectinmethicillinresistantstaphylococcusaureus
AT ashfordnathanielk synergybetweenbetalactamsandlipoglycoandlipoglycopeptidesisindependentoftheseesaweffectinmethicillinresistantstaphylococcusaureus
AT penewitkelsi synergybetweenbetalactamsandlipoglycoandlipoglycopeptidesisindependentoftheseesaweffectinmethicillinresistantstaphylococcusaureus
AT waalkesadam synergybetweenbetalactamsandlipoglycoandlipoglycopeptidesisindependentoftheseesaweffectinmethicillinresistantstaphylococcusaureus
AT holmeselizabetha synergybetweenbetalactamsandlipoglycoandlipoglycopeptidesisindependentoftheseesaweffectinmethicillinresistantstaphylococcusaureus
AT hineskellym synergybetweenbetalactamsandlipoglycoandlipoglycopeptidesisindependentoftheseesaweffectinmethicillinresistantstaphylococcusaureus
AT salipantestephenj synergybetweenbetalactamsandlipoglycoandlipoglycopeptidesisindependentoftheseesaweffectinmethicillinresistantstaphylococcusaureus
AT xulibin synergybetweenbetalactamsandlipoglycoandlipoglycopeptidesisindependentoftheseesaweffectinmethicillinresistantstaphylococcusaureus
AT werthbrianj synergybetweenbetalactamsandlipoglycoandlipoglycopeptidesisindependentoftheseesaweffectinmethicillinresistantstaphylococcusaureus